Effect of co-administration of metformin and extracts of Costus pictus D.Don leaves on alloxan-induced diabetes in rats

10.1016/j.jtcme.2021.08.007

Ami Naik；Sherif Babatunde Adeyemi；Bhavin Vyas；Ramar Krishnamurthy

Costaceae ； Hypoglycaemia ； Synergistic ； Insulin ； Histopathology

Journal of Traditional and Complementary Medicine

12卷3期（2022 / 05 / 01）

269 - 280

英文

Background and aim: The present study evaluates the antidiabetic effects of aqueous (CPAQ) and methanolic (CPME) extract of Costus pictus D. Don singly and/or in combination with metformin in alloxan-induced diabetic rats. Experimental procedure: CPAQ and CPME (400 mg/kg dose), metformin (120 mg/kg) and two different combinations of plant extracts and metformin (200 + 60 mg/kg and 400 mg/kg + 60 mg/kg) were orally given to alloxan-induced diabetic rats for 21 days. At 0, 7, 14, and 21 days, body weight and blood glucose levels were measured. Results and conclusion: After 21 days of treatment, biochemical profiling and histopathology analysis were carried out. CPAQ and CPME, when administrated separately, could decrease blood glucose levels (P ≤ 0.05). CPME showed more promising results (P ≤ 0.05) compared to the diabetic control group. Extracts co-administrated with metformin showed dose-dependent significant recovery of hypoglycemic activity of metformin. Fasting blood glucose levels, body weight, protein, and lipid profile of the treatment group were compared to the diabetic and normal control groups. Animal groups co-administered with CPME and metformin showed more significant effects on the recovery of tissue damages. The synergistic effect of plant extracts with metformin has positive effects on all the parameters and enhanced the efficiency and reduction of blood glucose levels.

1. Ojiako, OA,Chikezie, PC,Ogbuji, AC(2016).Blood glucose level and lipid profile of alloxan-induced hyperglycemic rats treated with single and combinatorial herbal formulations.J Trad Compl Med,6(2),184-192.
   連結：
2. Agbabiaka, T,Wider, B,Watson, LK,Goodman, C(2016).Concurrent use of prescription drugs and herbal medicinal products in older adults: a systematic review protocol.Syst Rev,5(1),65.
3. Al-Malki, AL,El Rabey, HA(2015).The antidiabetic effect of low doses of Moringa oleifera Lam. seeds on streptozotocin induced diabetes and diabetic nephropathy in male rats.BioMed Res Int,1-13.
4. Ami, N,Ramar, K,Janardan, P(2017).Comparative physicochemical and phytochemical evaluation for insulin plant-Costus pictus D. Don accessions.Int J Appl Agric Res,3(2),420-426.
5. Bailey, CJ(1992).Biguanides and NIDDM.Diabetes Care,15(6),755-772.
6. Bailey, CJ,Turner, RC(1996).Metformin.N. England J. Med.,334(9),574-579.
7. Baron, AD(1994).Hemodynamic actions of insulin.Am J Physiol Endocrinol Metabol,267(2),E187-E202.
8. Chandran, R,Parimelazhagan, T,Shanmugam, S,Thankarajan, S(2016).Antidiabetic activity of Syzygium calophyllifolium in Streptozotocin-Nicotinamide induced Type-2 diabetic rats.Biomed Pharmacother,82,547-554.
9. DeFronzo, RA,Abdul-Ghani, M(2011).Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose.Am J Cardiol,108(3),3B-24B.
10. Ekor, M(2014).The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety.Front Pharmacol,4,177.
11. Elavarasi, S,Saravanan, K(2012).Ethnobotanical study of plants used to treat diabetes by tribal people of Kolli Hills, Namakkal District, Tamilnadu, Southern India.Int J Pharm Tech Res,4(1),404-411.
12. Elkotby, D,Hassan, AK,Emad, R,Bahgat, I(2018).Histological changes in islets of Langerhans of pancreas in alloxan-induced diabetic rats following Egyptian honey bee venom treatments.Int J Pure Appl Zool,6(1),1-6.
13. Fernandes, AAH,Novelli, ELB,Okoshi, K(2010).Influence of rutin treatment on biochemical alterations in experimental diabetes.Biomed Pharmacother,64(3),214-219.
14. Fugh-Berman, A(2000).Herb-drug interactions.Lancet,355(9198),134-138.
15. Gopalakrishna, RN,Bannimath, G,Huded, SP(2017).Herb-drug interaction: effect of poly-herbal formulation on glibenclamide therapy in patients with type-2 diabetes mellitus.Pharmaceut Methods,8(1),62-70.
16. Gupta, R,Mathur, M,Bajaj, VK(2012).Evaluation of antidiabetic and antioxidant activity of Moringa oleifera in experimental diabetes.J Diabetes,4(2),164-171.
17. Halket, JM,Waterman, D,Przyborowska, AM,Patel, RK,Fraser, PD,Bramley, PM(2005).Chemical derivatization and mass spectral libraries in metabolic profiling by GC/MS and LC/MS/MS.J Exp Bot,56(410),219-243.
18. Hashmi, T(2011).,未出版
19. Hegde, PK,Rao, HA,Rao, PN(2014).A review on Insulin plant (Costus igneus Nak).Phcog Rev,8(15),67.
20. Hong, L,Xun, M,Wutong, W(2007).Anti-diabetic effect of an α-glucan from fruit body of maitake (Grifola frondosa) on KK-Ay mice.J Pharm Pharmacol,59(4),575-582.
21. Islam, MT,de Alencar, MVOB,da Conceição Machado, K(2015).Phytol in a pharma-medico-stance.Chem Biol Interact,240,60-73.
22. Kerner, W,Brückel, J(2014).Definition, classification and diagnosis of diabetes mellitus.Exp Clin Endocrinol Diabetes,122(7),384-386.
23. Knowler, WC,Barrett-Connor, E,Fowler, SE(2002).Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.N Engl J Med.,346(6),393-403.
24. Krishnasamy, G,Muthusamy, K,Chellappan, DR,Subbiah, N(2016).Antidiabetic, anti-hyperlipidaemic, and antioxidant activity of Syzygium densiflorum fruits in streptozotocin and nicotinamide-induced diabetic rats.Pharmaceut Biol,54(9),1716-1726.
25. Piero, M,Nzaro, G,Njagi, J(2014).Diabetes mellitus-a devastating metabolic disorder.Asian J Biomed Pharmaceut Sci,4(40),1-7.
26. Pitre, M,Nadeau, A,Bachelard, H(1996).Insulin sensitivity and hemodynamic responses to insulin in Wistar-Kyoto and spontaneously hypertensive rats.Am J Physiol Endocrinol Metabol,271(4),E658-E668.
27. Porchezhian, E,Ansari, S,Shreedharan, N(2000).Antihyperglycemic activity of Euphrasia officinale leaves.Fitoterapia,71(5),522-526.
28. Ramnanan, C,Edgerton, D,Kraft, G,Cherrington, A(2011).Physiologic action of glucagon on liver glucose metabolism.Diabetes Obes Metabol,13,118-125.
29. Reyes, B,Bautista, N,Tanquilut, N(2006).Antidiabetic potentials of Momordica charantia and Andrographis paniculata and their effects on estrous cyclicity of alloxan-induced diabetic rats.J Ethnopharmacol,105(1),196-200.
30. Rohilla, A,Ali, S.(2012).Alloxan induced diabetes: mechanisms and effects.Int J Res Pharmaceut Biomed Sci,3(2),819-823.
31. Sabu, M,Kuttan, R(2002).Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property.J Ethnopharmacol,81(2),155-160.
32. Sajid, M,Khan, MR,Ismail, H(2020).Antidiabetic and antioxidant potential of Alnus nitida leaves in alloxan induced diabetic rats.J Ethnopharmacol,251,112544.
33. Salpeter, SR,Greyber, E,Pasternak, GA,Salpeter, EE(2010).Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.Cochrane Database Syst Rev,1-233.
34. Shaw, JE,Sicree, RA,Zimmet, PZ(2010).Global estimates of the prevalence of diabetes for 2010 and 2030.Diabetes Res Clin Pract,87(1),4-14.
35. Shirwaikar, A,Rajendran, K,Kumar, CD,Bodla, R(2004).Antidiabetic activity of aqueous leaf extract of Annona squamosa in streptozotocin-nicotinamide type 2 diabetic rats.J Ethnopharmacol,91(1),171-175.
36. Stang, M,Wysowski, DK,Butler-Jones, D(1999).Incidence of lactic acidosis in metformin users.Diabetes Care,22(6),925-927.
37. Stumvoll, M,Nurjhan, N,Perriello, G,Dailey, G,Gerich, JE(1995).Metabolic effects of metformin in non-insulin-dependent diabetes mellitus.N Engl J Med.,333(9),550-554.
38. Ting, RZ-W,Szeto, CC,Chan, MH-M,Ma, KK,Chow, KM(2006).Risk factors of vitamin B12 deficiency in patients receiving metformin.Arch Intern Med.,166(18),1975-1979.
39. Visavadiya, NP,Narasimhacharya, A(2011).Ameliorative effects of herbal combinations in hyperlipidemia.Oxid Med Cell Longev,160408.
40. Whitton, PD,Hems, DA(1975).Glycogen synthesis in the perfused liver of streptozotocin-diabetic rats.Biochem J,150(2),153-165.